Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021

SELL
$16.3 - $17.26 $54,490 - $57,700
-3,343 Reduced 10.52%
28,449 $480,000
Q2 2021

Aug 12, 2021

BUY
$16.55 - $18.64 $244,393 - $275,256
14,767 Added 86.74%
31,792 $535,000
Q1 2021

Apr 26, 2021

BUY
$16.71 - $19.9 $241,041 - $287,057
14,425 Added 554.81%
17,025 $310,000
Q4 2020

Feb 02, 2021

SELL
$15.39 - $18.97 $30,780 - $37,940
-2,000 Reduced 43.48%
2,600 $47,000
Q2 2020

Jul 13, 2020

SELL
$14.59 - $19.5 $148,059 - $197,886
-10,148 Reduced 68.81%
4,600 $82,000
Q1 2020

Apr 29, 2020

BUY
$13.02 - $20.31 $192,018 - $299,531
14,748 New
14,748 $223,000
Q4 2019

Feb 05, 2020

SELL
$16.88 - $20.83 $36,562 - $45,117
-2,166 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$16.15 - $17.99 $34,980 - $38,966
2,166 New
2,166 $37,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.